Chemoradiation Therapy Versus Radiation Therapy Alone in T1-2 Oropharyngeal Cancer With Low-Volume Neck Disease: A Population-Based Cohort Study Using the Swedish Head and Neck Cancer Register
International Journal of Radiation Oncology*Biology*Physics · 2026
DOI: 10.1016/j.ijrobp.2025.08.040 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026. Verfasst von Gabriel Adrian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden; Department of Radiation Oncology, Princess Alexan…. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Chemoradiotherapy, Carcinoma, Squamous Cell. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mrs Berta Kamprad foundation for exploration and combat cancer, Swedish Society for Medical Research.
Abstract (Originalsprache)
PURPOSE: The benefit of adding concurrent systemic therapy to definitive radiation therapy (RT) for patients with T1-2 oropharyngeal squamous cell carcinoma (OPSCC) and limited neck node involvement is uncertain. This study investigates whether chemotherapy (CRT) in patients with early-stage (T1-2) low-volume nodal disease (Union for International Cancer Control Seventh Edition N1-2b) improves overall survival (OS) compared with RT alone. METHODS AND MATERIALS: A cohort study of data from the prospective Swedish Head and Neck Cancer Register leveraged variation in receiving CRT based on the health care region. Propensity score matching (1:1) was applied to balance baseline characteristics between patients from regions favoring CRT and those receiving RT alone. OS and loco-regional control (LRC) were compared between groups using Kaplan-Meier analyses and Cox regression models. Separate matching and analyses were conducted for patients with T1-2N1-2a (cohort N1-2a, ie, single node 70 years (HR, 1.48 [95% CI, 0.50-4.39]). The difference in LRC was driven by failures at the primary tumor site. Exploratory analyses suggested a selective benefit of CRT for patients with T2N2b. CONCLUSIONS: The results of this large, robust, national register suggest that RT alone is a safe treatment option for patients with T1-2N1-2a OPSCC. In patients with multiple neck nodes (N2b) aged ≤70 years, CRT improved LRC but not overall survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden; Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Division of Oncology, D…
- Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden.
- Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
- Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Förderung
- Mrs Berta Kamprad foundation for exploration and combat cancer
- Swedish Society for Medical Research
Zitieren
APA
Adrian, G., Falklind, N. R., McDowell, L., & Gebre-Medhin, M. (2026). Chemoradiation Therapy Versus Radiation Therapy Alone in T1-2 Oropharyngeal Cancer With Low-Volume Neck Disease: A Population-Based Cohort Study Using the Swedish Head and Neck Cancer Register. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.08.040
Vancouver
Adrian G, Falklind NR, McDowell L, Gebre-Medhin M. Chemoradiation Therapy Versus Radiation Therapy Alone in T1-2 Oropharyngeal Cancer With Low-Volume Neck Disease: A Population-Based Cohort Study Using the Swedish Head and Neck Cancer Register. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2025.08.040
BibTeX
@article{Adrian2026,
author = {Adrian, Gabriel and Falklind, Niclas Rudolfson and McDowell, Lachlan and Gebre-Medhin, Maria},
title = {Chemoradiation Therapy Versus Radiation Therapy Alone in T1-2 Oropharyngeal Cancer With Low-Volume Neck Disease: A Population-Based Cohort Study Using the Swedish Head and Neck Cancer Register},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
doi = {10.1016/j.ijrobp.2025.08.040}
}
EUVIMED